Meetings / Live CME


Collaborate with your peers and master the latest knowledge in your cardiovascular specialty.


2017 AHA Conferences

International Stroke Conference
Feb. 22–24 | Houston, Texas
EPI|Lifestyle
March 7–10 | Portland, Ore.
QCOR
April 2–3 | Arlington, Va.
ATVB|PVD
May 4–6 | Minneapolis, Minn.
BCVS
July 10–13 | Portland, Ore.
Council on Hypertension
September 14–17 | San Francisco, Calif.
Scientific Sessions
November 11–15 | Anaheim, Calif.

Add these dates to your calendar

Science NewsView All

New Circ CQO Twitter Journal Club
01/20/2017 | Circulation: Cardiovascular Quality and Outcomes announces announces new Twitter Journal Club.
ATVB January 2017 Issue
01/17/2017 | ATVB Editor's Pick and Featured Articles for January 2017

Key Highlights from Scientific Sessions 2016



Top Science Stories from Scientific Sessions 2016

Steve Houser, MD, president, American Heart Association, Frank Sellke, MD, and Eric Peterson, MD review the big science stories from Scientific Sessions 2016 in New Orleans.


Inhibition of PCSK9 Synthesis via RNA Interference: 90 Day Data From Orion-1-a Multi-centre Phase-2 Randomized Controlled Trial
Kausik K Ray | Imperial College of London, London, United Kingdom

RESULTS: At 180 days, inhibiting PCSK9 synthesis using RNA interference safely reduced LDL-C.


Manesh R. Patel

Effects of Ticagrelor Compared With Clopidogrel in Patients With Peripheral Artery Disease (EUCLID)
Manesh R Patel | Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

RESULTS: PAD patients did not gain more benefit from long-term ticagrelor compared to clopidogrel in preventing cardiovascular death, heart attack, or ischemic stroke. The primary endpoint was not met.

International Stroke Conference 2017

February 22–24, 2017
Houston, Texas

EPI-Lifestyle 2016 

March 7–10, 2017
Portland, Oregon

QCOR 2017
 

April 2–3, 2017
Arlington, Virginia